Thursday - July 16, 2026
Biosimilars Council and AAM Applauds House Introduction of the Expedited Access to Biosimilars Act
July 16, 2026
WASHINGTON, July 16 -- The Association for Accessible Medicines issued the following news release:

* * *

Biosimilars Council and AAM Applauds House Introduction of the Expedited Access to Biosimilars Act

Legislation codifies FDA's science-based approach to biosimilar review by limiting comparative efficacy studies

-

The Biosimilars Council and the Association for Accessible Medicines today applauded legislation, the Expedited . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products